---  
layout: startup_page  
title: "Beacon Therapeutics Holdings Limited"  
id: "beacontx.com"  
permalink: "/beacontherapeuticsholdingslimitedbeacontx.com07032024/"  
website: "https://www.beacontx.com/"  
funding_round: "Series B"  
funding_amount: "$170M"  
investors: "Forbion, Syncona Limited, Oxford Science Enterprises, TCGX, Advent Life Sciences"  
about: "Beacon Therapeutics is an ophthalmic gene therapy company focused on saving and restoring vision for patients with blinding retinal diseases. Their lead asset, AGTC-501, is in a registrational clinical trial for X-Linked Retinitis Pigmentosa, and they also have preclinical programs targeting dry age-related macular degeneration and cone-rod dystrophy."  
markets: "Ophthalmology, Gene Therapy, Biotechnology Research, Health Care, Therapeutics"  
hq: "Alachua, Florida, United States"  
founded_year: "2023"  
linkedin: "https://www.linkedin.com/company/beacon-therapeutics"  
twitter: "https://twitter.com/beacontx_"  
instagram: ""  
facebook: "https://www.facebook.com/BeaconTx"  
crunchbase: "https://www.crunchbase.com/organization/beacon-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/53524-27"  

date_display: "03-Jul-2024"  
date: "2024-07-03"

# SEO Optimization  
meta_title: "Beacon Therapeutics Holdings Limited - Series B Funding ($170M)"  
meta_description: "Beacon Therapeutics Holdings Limited, Beacon Therapeutics is an ophthalmic gene therapy company focused on saving and restoring vision for patients with blinding retinal diseases. Their le..."  
meta_keywords: "Beacon Therapeutics Holdings Limited, Ophthalmology, Gene Therapy, Biotechnology Research, Health Care, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/beacontherapeuticsholdingslimitedbeacontx.com07032024/"  
---